Transplantation of Bioprinted Tissues and Organs: Technical and Clinical Challenges and Future Perspectives

Dino Ravnic, Ashley N. Leberfinger, Srinivas Koduru, Monika Hospodiuk, Kazim K. Moncal, Pallab Datta, Madhuri Dey, Elias Rizk, Ibrahim Tarik Ozbolat

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

Three-dimensional (3D) bioprinting is a revolutionary technology in building living tissues and organs with precise anatomic control and cellular composition. Despite the great progress in bioprinting research, there has yet to be any clinical translation due to current limitations in building human-scale constructs, which are vascularized and readily implantable. In this article, we review the current limitations and challenges in 3D bioprinting, including in situ techniques, which are one of several clinical translational models to facilitate the application of this technology from bench to bedside. A detailed discussion is made on the technical barriers in the fabrication of scalable constructs that are vascularized, autologous, functional, implantable, cost-effective, and ethically feasible. Clinical considerations for implantable bioprinted tissues are further expounded toward the correction of end-stage organ dysfunction and composite tissue deficits.

Original languageEnglish (US)
Pages (from-to)48-58
Number of pages11
JournalAnnals of Surgery
Volume266
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Bioprinting
Tissue Transplantation
Organ Transplantation
Technology
Costs and Cost Analysis
Research

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Ravnic, Dino ; Leberfinger, Ashley N. ; Koduru, Srinivas ; Hospodiuk, Monika ; Moncal, Kazim K. ; Datta, Pallab ; Dey, Madhuri ; Rizk, Elias ; Ozbolat, Ibrahim Tarik. / Transplantation of Bioprinted Tissues and Organs : Technical and Clinical Challenges and Future Perspectives. In: Annals of Surgery. 2017 ; Vol. 266, No. 1. pp. 48-58.
@article{95f5141bc56d4b8ea7df8846a7551bdb,
title = "Transplantation of Bioprinted Tissues and Organs: Technical and Clinical Challenges and Future Perspectives",
abstract = "Three-dimensional (3D) bioprinting is a revolutionary technology in building living tissues and organs with precise anatomic control and cellular composition. Despite the great progress in bioprinting research, there has yet to be any clinical translation due to current limitations in building human-scale constructs, which are vascularized and readily implantable. In this article, we review the current limitations and challenges in 3D bioprinting, including in situ techniques, which are one of several clinical translational models to facilitate the application of this technology from bench to bedside. A detailed discussion is made on the technical barriers in the fabrication of scalable constructs that are vascularized, autologous, functional, implantable, cost-effective, and ethically feasible. Clinical considerations for implantable bioprinted tissues are further expounded toward the correction of end-stage organ dysfunction and composite tissue deficits.",
author = "Dino Ravnic and Leberfinger, {Ashley N.} and Srinivas Koduru and Monika Hospodiuk and Moncal, {Kazim K.} and Pallab Datta and Madhuri Dey and Elias Rizk and Ozbolat, {Ibrahim Tarik}",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/SLA.0000000000002141",
language = "English (US)",
volume = "266",
pages = "48--58",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Transplantation of Bioprinted Tissues and Organs : Technical and Clinical Challenges and Future Perspectives. / Ravnic, Dino; Leberfinger, Ashley N.; Koduru, Srinivas; Hospodiuk, Monika; Moncal, Kazim K.; Datta, Pallab; Dey, Madhuri; Rizk, Elias; Ozbolat, Ibrahim Tarik.

In: Annals of Surgery, Vol. 266, No. 1, 01.01.2017, p. 48-58.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Transplantation of Bioprinted Tissues and Organs

T2 - Technical and Clinical Challenges and Future Perspectives

AU - Ravnic, Dino

AU - Leberfinger, Ashley N.

AU - Koduru, Srinivas

AU - Hospodiuk, Monika

AU - Moncal, Kazim K.

AU - Datta, Pallab

AU - Dey, Madhuri

AU - Rizk, Elias

AU - Ozbolat, Ibrahim Tarik

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Three-dimensional (3D) bioprinting is a revolutionary technology in building living tissues and organs with precise anatomic control and cellular composition. Despite the great progress in bioprinting research, there has yet to be any clinical translation due to current limitations in building human-scale constructs, which are vascularized and readily implantable. In this article, we review the current limitations and challenges in 3D bioprinting, including in situ techniques, which are one of several clinical translational models to facilitate the application of this technology from bench to bedside. A detailed discussion is made on the technical barriers in the fabrication of scalable constructs that are vascularized, autologous, functional, implantable, cost-effective, and ethically feasible. Clinical considerations for implantable bioprinted tissues are further expounded toward the correction of end-stage organ dysfunction and composite tissue deficits.

AB - Three-dimensional (3D) bioprinting is a revolutionary technology in building living tissues and organs with precise anatomic control and cellular composition. Despite the great progress in bioprinting research, there has yet to be any clinical translation due to current limitations in building human-scale constructs, which are vascularized and readily implantable. In this article, we review the current limitations and challenges in 3D bioprinting, including in situ techniques, which are one of several clinical translational models to facilitate the application of this technology from bench to bedside. A detailed discussion is made on the technical barriers in the fabrication of scalable constructs that are vascularized, autologous, functional, implantable, cost-effective, and ethically feasible. Clinical considerations for implantable bioprinted tissues are further expounded toward the correction of end-stage organ dysfunction and composite tissue deficits.

UR - http://www.scopus.com/inward/record.url?scp=85020394950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020394950&partnerID=8YFLogxK

U2 - 10.1097/SLA.0000000000002141

DO - 10.1097/SLA.0000000000002141

M3 - Review article

C2 - 28594678

AN - SCOPUS:85020394950

VL - 266

SP - 48

EP - 58

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 1

ER -